Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Philip J. Almeter"'
Autor:
Philip J. Almeter, James T. Isaacs, Aaron N. Hunter, Bradley S. Henderson, Thomas Platt, Billie J. Mitchell, David Do, Alyssa B. Brainard, Joshua E. Brown, Rachael M. Stone, Bao-Han Nguyen, Matthew F. Warren, Smaran A. Bhaktawara, Megan N. Bossle, Lindsey M. Long, Stephanie P. Zapata, Cinnamon R. Larkin, Thomas A. Lyman, Seth A. Larkin, Jonathan A. Labuhn, Jeffrey W. Reynolds, Erin E. Schuler, Ryan W. Naseman, Gary L. Johnson, Robert A. Lodder
Publikováno v:
Journal of Pharmaceutical Innovation. 17:269-282
Since the US Food and Drug Administration (FDA) began monitoring the quality of pharmaceutical manufacturing by enforcing current good manufacturing practices roughly 60 years ago, forces related to the global economy have changed, rendering the task
Autor:
Philip J, Almeter, Wesley R, Butler, Jeffrey W, Reynolds, Deborah L, Duckworth, Jonathan A, Labuhn, Mark D, Birdwhistell
Publikováno v:
American Journal of Health-System Pharmacy. 79:1607-1611
Publikováno v:
Contact Context
Intra-lot and inter-lot variability in cosyntropin was detected in the DQS using Fourier transform near-infrared spectrometry. One vial of 12 sampled from Sandoz Lot0200062 appeared 6.9 SDs from the center of the rest of the vials, and another was 4.
Autor:
James T, Isaacs, Philip J, Almeter, Bradley S, Henderson, Aaron N, Hunter, Thomas L, Platt, Robert A, Lodder
Publikováno v:
Contact Context
Pemetrexed is a folate analog metabolic inhibitor used in treatment of locally advanced or metastatic nonsquamous non-small cell lung cancer and for mesothelioma. Intra-lot and inter-lot variability in the spectra of ALIMTA® was detected in the Drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::657a0f885da40548a2649f59436c8f61
Autor:
Philip J. Almeter, Robert A. Lodder
Publikováno v:
Journal of Pharmaceutical Innovation. 17:267-268
Publikováno v:
Anesthesia & Analgesia. 127:1414-1420
BACKGROUND:The purpose of the US Food and Drug Administration’s Marketed Unapproved Drugs Initiative is to decrease marketing of older unapproved medications. The administration has recently extended its rulings by including sterile injectable drug
Autor:
W Mike Heath, Max D. Ray, David A. Zilz, William E. Evans, William A. Zellmer, Debra S. Devereaux, Allen J. Flynn, Scott Knoer, Meghan Swarthout, Philip J. Almeter, James M. Hoffman, Sharon Murphy Enright, G Tyler Short, James G. Stevenson, Jill M. Kolesar, Lee C. Vermeulen, Pam Ploetz, Rafael Saenz, M. Lynn Crismon
Publikováno v:
American Journal of Health-System Pharmacy
Foreword {#article-title-2} The ASHP Research and Education Foundation (“the Foundation”) is pleased to present the sixth edition of the annual Pharmacy Forecast . While the first 4 editions of the Pharmacy Forecast were published as standalone r
Publikováno v:
American Journal of Health-System Pharmacy. 74:1013-1019
Since the 1983 amendments to the Social Security Act, hospitals have undergone a paradigm shift in their operations. Previously able to bill Medicare retrospectively for the actual costs of the care provided, hospitals since then have received capita
Publikováno v:
Anesthesia & Analgesia. 128:e55-e56
Autor:
Jonathan A. Labuhn, Christopher McLaughlin, Philip J. Almeter, Benjamin D. Turner, Philip Fields
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 74(15)
Purpose A successful supply chain optimization project that leveraged technology, engineering principles, and a technician workflow redesign in the setting of a growing health system is described. Summary With continued rises in medication costs, med